High-risk PCa is defined as a prostate-specific antigen (PSA) level > 20 ng/ml, a Gleason score of 8–10, or a clinical stage ≥ T2c according to the American Urological Association (AUA) guideline4, 5. Here, KLK3 is linked to posterior cortical atrophy.